Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase

6 Aug 2020

Abstract excerpt

The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), referred to as coronavirus disease 2019 (COVID-19), has caused over 13 million infections and over 560,000 deaths worldwide (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports), posing a significant threat to globally public health and economics. At present, no efficacious antiviral drugs and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biochemical and Molecular Research
Share to Hormonal Regulation and Hypertension
Share to Neonatal Health and Biochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32761523
DOI: 10.1007/s13238-020-00769-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenasePMID 32761523Read ↗

Unveiling the antiviral capabilities of targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2Semantic proximity Read ↗

The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human CoronavirusesSemantic proximity Read ↗

A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging VirusesSemantic proximity Read ↗

The new generation hDHODH inhibitor MEDS433 hinders the <i>in vitro</i> replication of SARS-CoV-2Semantic proximity Read ↗

N4-Hydroxycytidine and Inhibitors of Dihydroorotate Dehydrogenase Synergistically Suppress SARS-CoV-2 ReplicationSemantic proximity Read ↗

Current and Future Direct-Acting Antivirals Against COVID-19Semantic proximity Read ↗

N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replicationSemantic proximity Read ↗

Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 <i>in vitro</i> : Rationale for a host-acting antiviral treatment strategy for COVID-19Semantic proximity Read ↗

Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cellsSemantic proximity Read ↗

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoVSemantic proximity Read ↗

Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research StudySemantic proximity Read ↗

Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin LSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.